G01N 2333/928
Acting on alpha -1, 4-glucosidic bonds
Official title: acting on alpha -1, 4-glucosidic bonds, e.g. hyaluronidase, invertase, amylase
G01N2333/928 (Acting on alpha -1, 4-glucosidic bonds) appears on 49 US grants and 80 published applications in this corpus.
Search patents in G01N- Granted patents
- 49
- Published applications
- 80
- Assignees
- 36
- Inventors
- 137
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 3 |
| 2011 | 0 | 3 |
| 2012 | 0 | 3 |
| 2013 | 1 | 2 |
| 2014 | 4 | 2 |
| 2015 | 4 | 6 |
| 2016 | 2 | 5 |
| 2017 | 3 | 2 |
| 2018 | 2 | 4 |
| 2019 | 2 | 0 |
| 2020 | 3 | 5 |
| 2021 | 2 | 5 |
| 2022 | 1 | 3 |
| 2023 | 2 | 10 |
| 2024 | 16 | 10 |
| 2025 | 5 | 10 |
| 2026 | 2 | 7 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods for detecting and inhibiting brain metastasis28 Apr 2026US 12,613,245 B2Cornell University
- PH20 polypeptide variants, formulations and uses thereof14 Apr 2026US 12,600,959 B2Halozyme, Inc.
- PH20 polypeptide variants with a modification at position 324 of the PH20 polypeptide and a method of making thereof29 Jul 2025US 12,371,685 B2Halozyme, Inc.
- Binding proteins for the enzyme acid alpha glucosidase (GAA) and uses thereof29 Apr 2025US 12,286,458 B2Navigo Proteins GmbH
- PH20 polypeptide variants, formulations and uses thereof1 Apr 2025US 12,264,345 B1Halozyme, Inc.
- Ph20 polypeptide variants, formulations and uses thereof1 Oct 2026US 2026/0297551 A1Halozyme, Inc.
- Ph20 polypeptide variants, formulations and uses thereof17 Sep 2026US 2026/0275318 A1Halozyme, Inc.
- Ph20 polypeptide variants, formulations and uses thereof27 Aug 2026US 2026/0250652 A1Halozyme, Inc.
- Ph20 polypeptide variants, formulations and uses thereof6 Aug 2026US 2026/0226445 A1Halozyme, Inc.
- Ros-responsive theronostic biosensor18 Jun 2026US 2026/0166196 A1University of Manitoba
Most cited
By later US patents
- Method of conducting a droplet based enzymatic assay103US 8,440,392 B2Advanced Liquid Logic, Inc. · 2013
- PH20 polypeptide variants, formulations and uses thereof38US 9,447,401 B2Halozyme, Inc. · 2016
- Assay for measuring enzymatic modification of a substrate by a glycoprotein having enzymatic activity29US 9,140,635 B2Advanced Liquid Logic, Inc. · 2015
- PH20 polypeptide variants, formulations and uses thereof28US 11,041,149 B2Halozyme, Inc. · 2021
- PH20 polypeptide variants, formulations and uses thereof27US 11,066,656 B2Halozyme, Inc. · 2021